This inhibition impacts the expansion and differentiation of MDSCs mediated by these exosomes, alleviating gastric cancer progression in murine models and human patients by disrupting the delivery of exosomal PD-L1 to bone marrow cells (140). Here, CD274 is linked to gastric cancer.